Icecure Medical is trading 5.64% up at $2.06 in after-hours trading amid a strong September 21, 2026 market rally led by technology and growth stocks, alongside falling oil prices and lower Treasury yields.
- No new company-specific announcement was identified for September 21. The latest major catalyst was September 10 China NMPA approval for ProSense, enabling marketing in China, but it predates this move.
- The gain appears primarily macro-driven: S&P 500 up 1.51% and Nasdaq Composite up 2.52%.